BioSpace - Financial Content

Symbol 'NWBT' could not be found. Search For:

Thu, Jul 23, 2009
	Northwest Biotherapeutics Announces Plans to De-list From AIM and Consolidate its Stock Market Listing in U.S. - PR Newswire
Tue, Feb 17, 2009
	Update of Long-Term Data on Brain Cancer Patients Receiving DCVax(R)-Brain Continues to Show Striking Improvements in Delay of Disease and Survival - PR Newswire
Tue, Dec 23, 2008
	Northwest Biotherapeutics Reports Encouraging Data on First Patients Who Have Completed Its Phase I/II Clinical Trial of DCVax(R)-L in Metastatic Ovarian Cancer - PR Newswire
Thu, Oct 02, 2008
	Northwest Secures US$1.0 Million Debt Financing - PR Newswire
Thu, Sep 11, 2008
	Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain - PR Newswire
More Press Releases

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs